NCT03098160 2017-10-30Immunotherapy Study of Evofosfamide in Combination With IpilimumabThreshold PharmaceuticalsPhase 1 Unknown69 enrolled
NCT00495144 2012-07-27A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid TumorsThreshold PharmaceuticalsPhase 1 Completed129 enrolled